Related Experiment Video
Updated: Aug 8, 2026

Analysis of Cerebral Vasospasm in a Murine Model of Subarachnoid Hemorrhage with High Frequency Transcranial Duplex Ultrasound
Published on: June 3, 2021
Predictors of left ventricular regional wall motion abnormalities after subarachnoid hemorrhage
Avinash Kothavale1, Nader M Banki, Alexander Kopelnik
1Division of Cardiology, UCSF Medical Center, San Francisco, CA, USA.
Insights
Regional wall motion abnormalities (RWMA) are common after subarachnoid hemorrhage (SAH). High Hunt & Hess grade, elevated cardiac troponin I (cTi), stimulant drug use, and tachycardia predict RWMA development.
Area of Science:
- Cardiology
- Neurology
- Critical Care Medicine
Background:
- Subarachnoid hemorrhage (SAH) can lead to cardiac abnormalities, including left ventricular (LV) systolic dysfunction, but the underlying mechanisms are unclear.
- Previous reports indicate cardiac biomarker release and ECG changes following SAH.
Purpose of the Study:
- To determine the prevalence of LV regional wall motion abnormalities (RWMA) after SAH.
- To identify demographic and clinical predictors of RWMA development post-SAH.
Main Methods:
- Prospective study of 300 patients with SAH, utilizing serial echocardiography.
- Predictor variables included Hunt & Hess grade, age, gender, cardiac risk factors, aneurysm location, catecholamine levels, cardiac troponin I (cTi), heart rate (HR), blood pressure, and phenylephrine dose.
- Multivariate logistic regression analysis was performed to identify independent predictors of RWMA.
Main Results:
- RWMA were detected in 18% of the 300 patients studied (817 echocardiograms analyzed).
- Prevalence of RWMA was higher in patients with Hunt & Hess grades 3-5 (35%) and elevated peak cTi levels >1.0 µg/L (65%).
- Independent predictors of RWMA included high Hunt & Hess grade (OR 4.22), elevated cTi (OR 10.47), prior stimulant use (OR 5.50), and higher HR (OR 1.34 per 10 bpm increase).
Conclusions:
- Regional wall motion abnormalities (RWMA) are frequent following subarachnoid hemorrhage (SAH).
- High-grade SAH, elevated cardiac troponin I (cTi) levels, a history of stimulant drug use, and tachycardia are independent predictors of RWMA.
Introduction:
Cardiac abnormalities that have been reported after subarachnoid hemorrhage (SAH) include the release of cardiac biomarkers, electrocardiographic changes, and left ventricular (LV) systolic dysfunction. The mechanisms of cardiac dysfunction after SAH remain controversial. The aim of this study was to determine the prevalence of LV regional wall motion abnormalities (RWMA) after SAH and to quantify the independent effects of specific demographic and clinical variables in predicting the development of RWMA.
Methods:
Three hundred patients hospitalized with SAH were prospectively studied with serial echocardiography. The primary outcome measure was the presence of RWMA. The predictor variables included the admission Hunt & Hess grade, age, gender, cardiac risk factors, aneurysm location, plasma catecholamine levels, cardiac troponin I (cTi) level, heart rate (HR), blood pressure, and phenylephrine dose. Univariate and multivariate logistic regression was performed with adjustment for serial measurements, reporting odds ratios (OR) and 95% confidence intervals (CI).
Results:
In this study, 817 echocardiograms were analysed. RWMA were detected in 18% of those studied. The prevalence of RWMA in patients with Hunt & Hess grades 3 - 5 was 35%. Among patients with a peak cTi level greater than 1.0 m g/L, 65% had RWMA. Multivariate analysis demonstrated that high Hunt & Hess grade (OR 4.22 for grade 3 - 5 versus grade 1 - 2, p = 0.046), a cTi level greater than 1.0 microg/L (OR 10.47, p = 0.001), a history of prior cocaine or amphetamine use (OR 5.50, p = 0.037), and higher HR (OR 1.34 per 10 bpm increase, p = 0.024) were predictive of RWMA.
Conclusions:
RWMA were frequent after SAH. High-grade SAH, an elevation in cTi levels, a history of prior stimulant drug use, and tachycardia are independent predictors of RWMA.
Related Concept Videos
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
